OBJECTIVES: To investigate the prevalence and predictors of pulmonary hypertension (PH)
in patients with systemic lupus erythematosus (SLE) and to validate a diagnostic strategy. …

Antimalarials have shown beneficial effects on systemic lupus erythematosus (SLE) activity.
Our aim was to investigate whether antimalarials protect against thrombosis and influence …

Objectives. We aimed to establish the prevalence, predictors and clinical consequences of
vitamin D deficiency in patients with SLE. Methods. Cross-sectional study including patients …

Introduction Infections commonly complicate the course of systemic lupus erythematosus (SLE).
Our aim is to investigate the clinical predictors of major infections in patients with SLE. …

Background Thrombosis is a frequent cause of morbidity and death in patients with systemic
lupus erythematosus (SLE). Whether antiphospholipid syndrome (APS) is the cause of …

In this study, 1,833 systemic sclerosis (SSc) cases and 3,466 controls were genotyped with
the Immunochip array. Classical alleles, amino acid residues, and SNPs across the human …

Objective To analyze whether changes in serum 25‐hydroxyvitamin D (25[OH]D) levels
affect activity, irreversible organ damage, and fatigue in systemic lupus erythematosus (SLE). …

The incidence and severity of tuberculosis (TB) in patients with systemic lupus erythematosus
(SLE) varies greatly among different series. In addition, prospective data are scarce. The …

… MV Egurbide1, … Ruiz-Irastorza G, Egurbide MV, Pijoan JI, Garmendia M , Villar I ,
Martinez-Berriotxoa A , et al. Effect of antimalarials on thrombosis and survival in patients with …

Peak age at onset of systemic sclerosis (SSc) is between 20 and 50 years, although SSc is
also described in both young and elderly patients. We conducted the present study to …